U.S. Imaging Services Market Size, Share and Trends | 2030

U.S. Imaging Services Market Size, Share & Trends Analysis 2030

U.S. Imaging Services Market Size & Trends

The US Imaging Services Market is poised to expand at a CAGR of 4.3% from 2025 to 2030, driven by the rising incidence of cancer and cardiac disorders, as well as growing consumer awareness about medical imaging technology. For instance, recent data from the International Agency for Research on Cancer reveals that over 2.38 million new cancer cases were reported in the US in 2022, with this number projected to reach approximately 7.85 million by 2028. Furthermore, advancements in technologies aimed at enhancing medical imaging services are expected to significantly contribute to market growth during the forecast period.

Medical imaging plays a pivotal role in providing accurate diagnoses while ensuring patient safety and speed. Utilizing various imaging modalities, such as X-ray, ultrasound, nuclear medicine scans, MRI, and CT scans, these services enable healthcare professionals to diagnose a wide range of diseases with minimal invasive procedures. This facilitates early detection, ultimately leading to improved treatment outcomes. The advent of advanced technologies is anticipated to propel market growth in the forthcoming years. Factors contributing to this growth include the rapidly increasing elderly population and rising cancer incidence rates. Additionally, substantial funding for ongoing research initiatives and collaborative private-public projects are likely to drive overall market expansion.

Medical imaging plays a vital role in facilitating timely and accurate diagnoses, ultimately contributing to the efficacy of treatment plans. As a result, medical professionals increasingly rely on these technologies as a precursor to surgical interventions. The escalating incidence of cancer and cardiovascular diseases is expected to heighten demand for diagnostic services. In fact, according to data from the Centers for Disease Control and Prevention (CDC), approximately 33 seconds pass before someone succumbs to cardiovascular disease, with a staggering 702,880 deaths recorded in 2022 - a sobering reminder of its prevalence.

In interventional radiology, healthcare professionals harness medical imaging systems to navigate minimally invasive surgical procedures that not only diagnose but also treat a wide range of conditions effectively. Utilizing cutting-edge imaging modalities like CT, fluoroscopy, ultrasound, and MRI, these specialists are able to deliver precise care with remarkable outcomes. The benefits of minimally invasive surgeries are multifaceted - they enable faster recovery times, smaller incisions that result in less scarring, decreased pain levels, improved accuracy, and ultimately shorter hospital stays compared to traditional open surgery techniques. This shift towards minimally invasive procedures is likely to drive market growth, as the advantages become increasingly apparent.

Market Characteristics & Concentration

The US imaging services industry is currently experiencing a moderate growth phase, with an accelerating pace of expansion. As chronic disorders continue to rise, coupled with increasing awareness about the benefits of advanced medical imaging techniques, demand for these services is on the upswing. Furthermore, the proliferation of outpatient settings that offer imaging services has contributed to this trend. However, factors such as high costs associated with imaging technologies and a shortage of skilled radiologists proficient in operating equipment are expected to temper growth prospects over the forecast period.

The U.S. imaging services industry is witnessing a dynamic landscape, with key players employing various strategic initiatives to maintain their market presence. Notably, Unilabs formed a partnership with SmartSoft Healthcare in April 2023, integrating AI-driven lumbar spine MRI reading and reporting capabilities. This collaboration showcases the industry's emphasis on leveraging advanced technologies to optimize efficiency and accuracy in diagnostic imaging services.

The U.S. imaging services industry continues to push boundaries with emerging technologies and techniques, driving growth and evolution. Over the past few years, the demand for diagnostic imaging services has surged, leading to a significant increase in the adoption of advanced imaging modalities such as MRI, CT, and PET-CT. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) algorithms is transforming medical imaging, poised to further boost innovation in the industry.

The US imaging services industry is witnessing an uptick in strategic partnerships and collaborations, as companies look to expand their offerings and reach a wider customer base. By pooling their strengths and expertise, businesses can deliver enhanced customer solutions and services. Furthermore, these partnerships can help reduce costs and boost efficiency through resource sharing and knowledge exchange. As demand for imaging services continues to rise, more collaborative ventures are on the horizon. Notably, RadNet, Inc. made a significant move in November 2022 by acquiring an 75% majority stake in Heart & Lung Imaging Limited, a London-based firm focused on improving lung cancer patient outcomes through early detection and precise diagnosis.

The US imaging services industry is deeply rooted in a complex web of regulations designed to safeguard patient well-being, maintain confidentiality, and ensure the responsible handling and disposal of medical equipment. Key regulatory bodies such as the FDA and CMS exert substantial influence over the sector. Moreover, legislation like the Affordable Care Act and MACRA promotes value-based care and encourages the adoption of innovative technologies. Operating within this stringent framework, the industry navigates a multifaceted landscape of federal and state-level laws that significantly shape its operations.

The U.S. medical imaging services industry operates in a unique landscape, where low threat from direct substitutes provides a level playing field for innovation. Conversely, emerging technologies like telemedicine and remote monitoring offer attractive alternatives to traditional methods, catering to patients with mobility or access limitations. Industry players are pitted against each other in a fiercely competitive environment, where value is determined by factors such as pricing, service quality, and geographical reach.

As imaging centers continue to grow nationwide, several U.S.-based facilities are venturing beyond their home states to reach a broader patient base. A notable example is the strategic partnership formed in April 2023 between MetroHealth's Lumina Imaging and Siemens Healthineers. The collaboration aims to expand affordable outpatient imaging services across the country, offering improved access to essential diagnostic solutions for patients. Under this partnership, Siemens Healthineers will exclusively supply MRI and CT equipment for all future Lumina sites, encompassing both corporate-owned and franchise locations. This expansion has yielded numerous benefits, including enhanced patient care and more widespread availability of vital imaging services.

Get A Free Sample Research Report PDF

https://www.theresearchinsights.com/reports/u-s-imaging-services-market-284/request-sample

Modality Insights

The nuclear medicine scan segment dominated the market in 2024, accounting for a significant 24.31% share. The rising awareness among physicians and clinical researchers about the benefits of nuclear imaging technology, as well as its expanding applications in oncology and neurological disorders, have significantly contributed to this growth. Furthermore, collaborative efforts between market players have further fueled the industry's expansion. Notably, a strategic partnership formed in October 2024 between Jubilant Radiopharma and Simplified Imaging Solutions has been instrumental in driving this trend. The collaboration aims to enhance nuclear medicine services across US healthcare facilities by integrating radiopharmacy networks with diagnostic services. This integrated approach offers a comprehensive solution that is both cost-effective and streamlined, thereby reducing administrative burdens for nuclear labs.

Moreover, the magnetic resonance imaging segment is poised to experience significant growth at a CAGR of 4.7% over the forecast period, driven by factors such as an aging population, cutting-edge technology like hybrid MRI equipment, high-field MRI, and superconducting magnets, as well as the increasing accessibility of healthcare services and rising chronic disease burdens, all of which are contributing to market expansion.

End-use Insights

Hospitals are projected to dominate the market with a significant share of 38.56% in 2024, driven by rising cases of cancer and cardiac disorders. The extensive availability of imaging modalities under one roof and favorable reimbursement policies for these procedures will likely fuel growth in this segment. Furthermore, hospitals are increasingly being recognized as key players in expanding imaging services across the country, with notable collaborations like Inspira Health Network's partnership with Atlantic Medical Imaging (AMI) and Regional Diagnostic Imaging (RDI). This joint venture aims to enhance patient experience, streamline scheduling, and expand services at multiple locations, rebranding six centers under a new umbrella.

The rise of outpatient imaging services is transforming the diagnostics landscape, with diagnostic imaging centers poised for significant growth in the market. As healthcare shifts towards value-based care, providers are opting for lower-cost, patient-centric settings that offer greater convenience. The integration of cutting-edge technologies like AI-assisted diagnostics and portable imaging solutions has enabled diagnostic centers to deliver faster, more accurate results. In response to these advancements, many imaging centers are broadening their service offerings to include innovative modalities such as PET-CT and 3D mammography. This strategic expansion is attracting a larger patient base and solidifying their market presence.

Key U.S. Imaging Services Company Insights

In a highly competitive market, top players in the US are actively seeking strategic collaborations to elevate patient care and imaging services. Notably, key companies have been exploring synergies through partnerships, mergers & acquisitions, and cooperative initiatives. For example, Medtronic recently announced a partnership with NVIDIA at their 2023 GTC conference, where they aim to accelerate AI integration into healthcare systems and introduce innovative AI-based solutions for patient care. This marks just one of several significant collaborations in the pipeline, as Medtronic seeks out additional partnerships leveraging AI and metaverse technologies to advance medical imaging and device development.

Recent Development

• In October 2024, IKS Health partnered with Radiology Partners to enhance radiology services using its AI-powered Care Enablement Platform. This collaboration aims to streamline workflows, reduce administrative burdens, and improve imaging access, allowing over 3,900 radiologists to dedicate more time to patient care.

• In July 2024, Rayus Radiology partnered with AI startup Ezra to introduce whole-body MRI services in Seattle, aiming to detect early-stage cancers and over 500 other conditions across 13 organs. This collaboration addresses the growing demand for comprehensive disease monitoring.

• In April 2024, Ezra Health partnered with RAYUS Radiology to offer AI-enabled full-body MRI scans at 150 RAYUS locations across the U.S. Ezra's technology monitors for over 500 conditions in 13 organs, aiming to detect diseases early. Their Ezra Flash software, FDA-approved in 2023, enhances MRI efficiency and image quality.

• In February 2023, Radnet, Inc. introduced an enhanced breast cancer detection program in New Jersey and New York. This imaging service network will benefit patients with an enhanced screening mammography service for cancer detection.

U.S. Imaging Services Market Report Scope

U.S. Imaging Services Market Report Segmentation

This comprehensive report projects revenue growth at the national level while offering a detailed examination of the latest industry shifts across each segment between 2018 and 2030. Building on its extensive research capabilities, The Research Insights has segmented the U.S. imaging services market into two primary categories: modality and end-use.

• Modality Outlook (Revenue, USD Billion, 2018 - 2030)

  • X-rays

  • CT scans

  • Nuclear medicine scans

  • MRI scans

  • Ultrasound

  • Mammography

• End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals

  • Diagnostic imaging centers

  • Others